Urinalysis Market Size, Share, and Trend Analysis, By Product Type (Consumables, Instruments), By Test Type (Biochemical, Microscopic, Sediment, and Others), By Application (Diagnosis, Diabetes, UTIs, and Others), By End-Use (Diagnostic laboratories, Hospitals & Clinics, Home care settings, and Others), and By Region, Forecast 2025-2032

Urinalysis Market Overview and Key Insights:

The global urinalysis market size reached USD 4,347.8 Million in 2024 and is expected to register a revenue CAGR of 9.3% during the forecast period. The rising incidence of chronic kidney diseases is driving revenue growth of the urinalysis market. Urinalysis plays a central role in screening for early signs of kidney dysfunction, such as proteinuria, hematuria, and abnormal sediment levels.

According to the International Society of Nephrology (ISN), the global prevalence of CKD stands at 10.4% among men and 11.8% among women. Additionally, acute kidney injury (AKI) affects approximately 13.3 million individuals annually, a condition that often progresses to CKD or end-stage renal disease if left unmanaged.

Market Drivers:

Every year, around 6 million people worldwide are diagnosed with urinary tract infections (UTIs), according to the National Center for Biotechnology Information. UTIs are the most common outpatient infections, with a lifetime incidence of 50-60% in adult women. The prevalence increases with age, with women over 65 experiencing twice the rate. UTIs create a significant societal and personal burden, with recurrent infections leading to increased absenteeism and physician visits.

Nonantimicrobial prophylactic strategies can reduce UTI rates and patient burdens. In response, several companies are developing advanced biosensor technologies to detect biomolecules in urine, providing sensitivity, selectivity, and reusability for health monitoring. Government and nonprofit organizations are launching initiatives to raise awareness about urinalysis, which will boost growth in the global urinalysis market.

Market Opportunity:

Growing geriatric population is expected to drive significant revenue growth over the forecast period. According to the World Health Organization (WHO), by 2030, one in six people globally will be aged 60 years or older, with the population in this age group rising from 1 billion in 2020 to 1.4 billion. The number is expected to double to 2.1 billion by 2050, and the population aged 80 and above will triple, reaching 426 million.

The older citizens require routine screening to manage multiple comorbidities, which as a result drives the requirement of frequent and accessible testing methods. Healthcare systems are prioritizing efficiency and early intervention for aging populations, driving significant traction for automated urinalysis systems, point-of-care devices, and home-based urine monitoring platforms.

Market Trends:

Non-Invasive Point-of-Care Testing is emerging as a major trend in the urinalysis market. Point-of-care (POC) testing of a wide range of biomarkers for both physiological and pathological levels require complex instrumentation. Urinalysis is an accessible and scalable diagnostic solution across diverse clinical uses. These low-abundance biomarkers are instrumental in the early detection of cancer.

Restraints & Challenges:

Lack of skilled employees in laboratories is expected to hinder the revenue growth of the urinalysis test. There is a scarcity of educated laboratory personnel who can perform urine tests reliably and effectively in many developing countries. This shortage may limit the capacity of healthcare facilities to perform urine testing, reducing demand for testing and limiting market growth.

Moreover, the high cost of urine tests and limited healthcare access in developing countries are significant challenges that might hinder growth in the global urinalysis market. Furthermore, challenges like the US excise tax and complicated regulatory procedures could limit market expansion.

Product Type Segment Insights and Analysis:

Based on the Product Type, the urinalysis market is segmented into consumables and instruments.

The consumables segment contributed the largest revenue share in 2024. This is attributed to a rise in demand for advanced urinary consumables as they are easy to use, convenient to handle, and can be stored for a longer duration without compromising their quality. For instance, on February 17th, 2023, Travere Therapeutics received FDA approval for FILSPARI, a single-molecule Dual Endothelin Angiotensin Receptor Antagonist, to reduce proteinuria in adults with primary IgA nephropathy at risk of rapid disease progression. Moreover, the demand for accurate urinalysis treatment is propelling demand. Advancements in product development to improve drug efficacy will significantly drive revenue growth over the forecast period.

Application Segment Insights and Analysis:

Based on the application, the urinalysis market is segmented into diagnosis, diabetes, urinary tract infections (UTIs), pregnancy & fertility, liver diseases, and others.

The urinary tract infection segment accounted for a substantial share in 2024. The increasing frequency of UTIs accounts for the substantial revenue share. According to the National Library of Medicine, every year, around 150 million people worldwide suffer from urinary tract infections. Urinalysis is a critical screening test for diabetes.

According to WHO, around 422 million people worldwide have diabetes, with 1.5 million deaths attributed to the disease each year. Urinalysis tests contribute to diagnosing and screening a variety of ailments, such as urinary tract infections (UTIs), kidney disease, and diabetes, hence supporting the development of the market. These are the factors expected to fuel the strategic demand for the market over the forecast period.

End-Use Segment Insights and Analysis:

Based on the end-use, the urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings, and research laboratories & institutes.

The diagnostic laboratories segment is expected to contribute a substantial share by 2032. The widespread use of urinalysis products in hospitals and clinics is increasing the growth rate. Furthermore, urinalysis gives quick and relatively accurate results, making it an important tool for healthcare providers in diagnostic laboratories to detect and treat numerous illnesses, leading to a surge in demand for urinalysis instruments in diagnostic laboratories. This can be due to patients’ ease of access and the availability of contemporary products in these laboratories.

Various clinical laboratories worldwide perform clinical tests such as urinalysis. Due to the rising launch of home-based UTI test kits, the home care category is expected to grow at a substantial CAGR during the forecast period. For instance, on 12 July 2022, Healthy.io received FDA approval for the Minuteful Kidney test, a smartphone-based diagnostic tool for early detection of chronic kidney disease using ACR, colorimetric analysis, and AI technologies.

Geographical Outlook:

The Urinalysis Market is strategically segmented by geography to provide a comprehensive understanding of regional market dynamics. Discover demand analysis, emerging trends, and growth opportunities shaping market performance across different regions and countries.

North America Urinalysis Market:

North America registered the highest market revenue share in the urinalysis market. This region holds around 35.5% market revenue share in 2024, owing to the rising incidence of chronic kidney disease (CKD). According to the National Institute of Diabetes and Digestive and Kidney Diseases, Chronic kidney disease (CKD) affects over 1 in 7 U.S. adults, with diabetes and high blood pressure being the most common causes.

Despite its prevalence, 9 in 10 adults with CKD are not aware of their condition. Kidney disease often worsens over time, leading to kidney failure and other health problems. Approximately 2 in 1,000 Americans live with end-stage kidney disease (ESKD), which requires a kidney transplant or dialysis. Diabetes is a common chronic disease in North America, and it has been associated with different urine compositions.

Furthermore, the increased frequency of urinary tract infections (UTIs) has accelerated the demand for urinalysis across the United States. According to the National Institute of Health (NIH), UTIs are the most prevalent outpatient infections in the United States. UTIs are more common with age. Women over 65 years old have a frequency of almost 20% compared to 11% in the general population. Urinary diagnostic test is highly required for urinary tract infections (UTIs), which, as a result, accelerate revenue growth of the market.

Asia Pacific Urinalysis Market:

Asia Pacific is expected to register the fastest revenue growth, reaching 12.9% by 2032. The rising incidence of type-1 and type-2 diabetes is driving demand in this region. Urinalysis plays a critical role in the early detection and monitoring of diabetes-related complications, such as kidney damage (diabetic nephropathy), urinary tract infections, and glucose levels in urine. According to the American Diabetes Association (ADA), Asia is home to more than 60% of all diabetics, with China and India accounting for over half. The prevalence of diabetes is expected to rise significantly across Asia Pacific, as a result, the demand is projected to rise.

The rising prevalence of infertility and the increasing age of first pregnancy are driving the adoption of urinalysis. Growing demand for pregnancy tests, which help detect high blood sugar levels and gestational diabetes, along with the affordability of pregnancy urine tests, is expected to fuel the growth of the global urinalysis market. On 28th July 2023, Hong Kong-based BPEA EQT announced it will acquire a majority stake in Indira IVF, India’s largest fertility services provider, valued at over USD 1.22 billion. Furthermore, increasing foreign direct investments (FDI) in the healthcare sector are expected to drive significant growth by 2032. On September 8, 2024, China loosened limitations on FDI in the healthcare industry.

Europe Urinalysis Market:

Europe contributed a substantial revenue share in 2024. Increasing chronic kidney diseases and the rise of point-of-care diagnostics are contributing to revenue growth in this region. The desk-bound lifestyle and lack of good health contribute to the demand for routine health checks.

European players are shifting focus to emerging markets owning high disease prevalence, large patient populations, medical tourism, improved infrastructure, and rising disposable income, leading to increased urinalysis market growth. Technological advancements are transforming the market dynamics of urinalysis testing. Also, the growing geriatric population in developed and developing countries drives the market.

Competition Analysis:

The Urinalysis Market is characterized by numerous players, with major players competing across segments and regions. The list of major players included in the Urinalysis Market report is:

1. Siemens Healthineers (Germany)
2. Beckman Coulter (USA)
3. Thermo Fisher Scientific Inc. (USA)
4. Sysmex Corporation (Japan)
5. Roche Diagnostics (Switzerland)
6. ARKRAY Inc. (Japan)
7. 77 Elektronika (Hungary)
8. Acon Laboratories (USA)
9. Bio-Rad Laboratories (USA)
10. Cardinal Health (USA)
11. Mindray Medical International (China)
12. Abbott Laboratories (USA)
13. Sysmex Corporation (Japan)
14. Starling Medical (USA)

Strategic Developments in the Urinalysis Market:

• On 27th January 2023, Starling Medical is preparing to roll out its at-home urine diagnostics and patient monitoring platform StarStream, a system that eliminates the need for conventional urine collection cups or dipsticks. The catheter monitors residual urine in the bladder to identify signs of urinary tract infections by leveraging AI and spectroscopy-based sensors.
• On 27^th September 2022, Sysmex Corporation introduced the UF-1500 Fully Automated Urine Particle Analyzer, a compact solution designed for urine sediment analysis. This new system retains the advanced features and user-friendly interface of the company’s flagship model, the UF-5000, while offering a more space-efficient design. Sysmex aims to deliver flexible solutions suited to varying clinical environments, particularly targeting the workflow needs of small to mid-sized laboratories.

Key Advantages for Stakeholders:

Navistrat Analytics’ industry report provides an in-depth quantitative analysis of various market segments, historical and current trends, market forecasts, and dynamics within the global market. The historical years covered in this report are 2022 to 2023, with 2024 serving as the base year for market size calculations. The forecast period extends from 2025 to 2032.

The report includes an executive summary and a comprehensive overview of market drivers, restraints, opportunities, and challenges (DROC), along with insights into regulatory standards. It features detailed analyses such as PORTER’s Five Forces, SWOT, and PESTLE, as well as assessments of technological trends and the competitive landscape.

PORTER’s Five Forces analysis helps stakeholders evaluate the impact of new entrants, competitive rivalry, supplier power, buyer power, and substitution threats, enabling them to assess the level of competition and the attractiveness of the global market. The competitive landscape provides stakeholders with a clear understanding of the current market positions of key players, offering valuable insights into their competitive environment.

Scope And Key Highlights of The Urinalysis Market Report:

The Urinalysis Market report offers a detailed analysis of market size, including historical revenue (in USD Million) data for 2022-2023 and revenue forecasts for 2025-2032 across the following segments:

• Product Type Outlook (Revenue, USD Million; 2022-2032)
  • Consumables
    • Dipsticks
    • Disposables
    • Reagents
  • Instruments
    • Automated urine analyzers
    • Semi-Automated urine analyzers
    • Portable urine analyzers

• Test Type Outlook (Revenue, USD Million; 2022-2032)
  • Biochemical
  • Microscopic
  • Sediment
  • Others

• Application Outlook (Revenue, USD Million; 2022-2032)
  • Diagnosis
  • Diabetes
  • Urinary Tract Infections (UTIs)
  • Pregnancy & fertility
  • Liver diseases
  • Others

• End-Use Outlook (Revenue, USD Million; 2022-2032)
  • Diagnostic laboratories
  • Hospitals & Clinics
  • Home care settings
  • Research laboratories & Institutes

• Regional Outlook (Revenue, USD Million; 2022-2032)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Benelux
    • Nordic Countries
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Oceania
    • ASEAN Countries
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Frequently Asked Questions (FAQ) About the Urinalysis Market Report